Heterobifunctional degraders rely on the formation of productive ternary complexes to activate cellulardegradative machinery, causing the proteolysis of a protei...

The numbers that have long defined traditional drug discovery are, by any measure, daunting. Bringing a singlenew medicine to market can take over a decade and c...

After decades of relying on established and proven methods, the biopharma manufacturing sector is nowchanging quickly. Increasing pressures across global supply ...

Scientific software is being purpose-built and adopted across all aspects of biopharma workflows. Biotech andpharmaceutical organisations of all sizes and modali...

To combat escalating R&D costs, high clinical attrition and stringent global pricing pressures, the biopharmaceutical industry is on a quest to find the best...

The need for speed in clinical trials is becoming a strategic imperative for sponsors, with looming patent cliffs, rising R&D investment, increasing innovati...